Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness

2004 ◽  
Vol 54 (2) ◽  
pp. 203-233 ◽  
Author(s):  
Allen C. Sherman ◽  
Molyn Leszcz ◽  
Julie Mosier ◽  
Gary M. Burlingame ◽  
Trish Cleary ◽  
...  
Keyword(s):  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer ◽  
Disease Outcomes

Group Interventions for Patients With Cancer and HIV Disease: Part I: Efficacy at Different Phases of Illness

2013 ◽  
Author(s):  
Allen C. Sherman ◽  
Gary M. Burlingame ◽  
Trish Cleary ◽  
Bernhard Strauss ◽  
Umaira Latif ◽  
...  
Keyword(s):  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer

Group Interventions for Patients with Cancer and HIV Disease: Part III. Moderating Variables and Mechanisms of Action

2004 ◽  
Vol 54 (3) ◽  
pp. 347-387 ◽  
Author(s):  
Allen C. Sherman ◽  
Julie Mosier ◽  
Molyn Leszcz ◽  
Gary M. Burlingame ◽  
Kathleen Hubbs Ulman ◽  
...  
Keyword(s):  
Mechanisms Of Action ◽  
Hiv Disease ◽  
Group Interventions ◽  
Moderating Variables ◽  
Patients With Cancer

Group Interventions for Patients with Cancer and HIV Disease: Part I: Effects on Psychosocial and Functional Outcomes at Different Phases of Illness

2004 ◽  
Vol 54 (1) ◽  
pp. 29-82 ◽  
Author(s):  
Allen C. Sherman ◽  
Julie Mosier ◽  
Molyn Leszcz ◽  
Gary M. Burlingame ◽  
Kathleen H. Ulman ◽  
...  
Keyword(s):  
Functional Outcomes ◽  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer

Group Interventions for Patients with Cancer and HIV Disease: Part IV. Clinical and Policy Recommendations

2004 ◽  
Vol 54 (4) ◽  
pp. 539-556 ◽  
Author(s):  
Molyn Leszcz ◽  
Allen Sherman ◽  
Julie Mosier ◽  
Gary M. Burlingame ◽  
Trish Cleary ◽  
...  
Keyword(s):  
Policy Recommendations ◽  
Hiv Disease ◽  
Group Interventions ◽  
Patients With Cancer

scholarly journals Timing is everything: Antiretroviral nonadherence is associated with impairment in time-based prospective memory

2009 ◽  
Vol 15 (1) ◽  
pp. 42-52 ◽  
Author(s):  
STEVEN PAUL WOODS ◽  
MATTHEW S. DAWSON ◽  
ERICA WEBER ◽  
SARAH GIBSON ◽  
IGOR GRANT ◽  
...  
Keyword(s):  
Prospective Memory ◽  
Psychiatric Comorbidity ◽  
Hiv Disease ◽  
Memory Functioning ◽  
Medication Monitoring ◽  
Disease Outcomes ◽  
Immunodeficiency Virus ◽  
Future Intention ◽  
Electronic Medication Monitoring ◽  
Predictors Of Adherence

AbstractNonadherence to combination antiretroviral (ARV) therapies (cART) is highly prevalent and significantly increases the risk of adverse human immunodeficiency virus (HIV) disease outcomes. The current study evaluated the hypothesis that prospective memory—a dissociable aspect of episodic memory describing the ability to execute a future intention—plays an important role in successful cART adherence. Seventy-nine individuals with HIV infection who were prescribed at least one ARV medication underwent a comprehensive neuropsychological and neuromedical evaluation prior to completing a 1-month observation of their cART adherence as measured by electronic medication monitoring. Nonadherent individuals (n = 31) demonstrated significantly poorer prospective memory functioning as compared to adherent persons (n = 48), particularly on an index of time-based ProM (i.e., elevated loss of time errors). Deficits in time-based prospective memory were independently predictive of cART nonadherence, even after considering the possible influence of established predictors of adherence, such as general cognitive impairment (e.g., retrospective learning and memory) and psychiatric comorbidity (e.g., depression). These findings extend a nascent literature showing that impairment in time-based prospective memory significantly increases the risk of medication nonadherence and therefore may guide the development of novel strategies for intervention. (JINS, 2009, 15, 42–52.)

Sign in / Sign up

Export Citation Format

Share Document